Liver stiffness measurement by transient elastography in clinical practice

Journal of Gastrointestinal and Liver Diseases

Volumn 17, Issue 4, 2008, Pages 395-399

  Sporea, Ioan ^a   Şirli, Roxana ^a   Deleanu, Alexandra ^a,b   Popescu, Alina ^a   Cornianu, Marioara ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NONE   (Romania)

Author keywords

Chronic liver diseases; Liver biopsy; Transient elastography

Indexed keywords

HEPATITIS B ANTIGEN;

ADULT; ARTICLE; BODY MASS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; ELASTOGRAPHY; FEMALE; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADULT; AGE FACTORS; BIOPSY; BODY MASS INDEX; CARRIER STATE; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 66549122836     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47.
2. Portincasa P. Non-Alcoholic steatohepatitis (NASH): approaching more tailored and effective therapies. J Gastrointest Liver Dis 2007; 16: 167-169.
3. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. The emerging problem of nonalcoholic steatohepatitis (NASH). Rom J Gastroenterol 2005; 14: 43-51.
4. Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis. Med Clin North Am 1996; 80: 1147-1166.
5. McHutchison J, Poynard T, Afdhal N; International Fibrosis Group Meeting Participants. Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group. Clin Gastroenterol Hepatol 2006; 4: 1214-1220.
6. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
7. Persico M, Palmentieri B, Vecchione R, Torella R, de SI. Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. Am J Gastroenterol 2002; 97: 491-492
8. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906.
9. Munteanu M. Non-invasive biomarkers FibroTest-ActiTest for replacing invasive liver biopsy: the need for change and action. J Gastrointest Liver Dis 2007; 16: 173-174.
10. Dietrich CF. Elastosonography, a new ultrasound modality. Acta Endoscopica 2006; 5: 777-778.
11. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, FibroTest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
12. Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18: 411-412.
13. Ogawa E, Furusyo N, Toyoda K, et al. Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis. Hepatol Res 2007; 37: 1002-1010.
14. Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43: 1118-1124.
15. Yoneda M, Yoneda M, Mawatari H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008; 40: 371-378.
16. Zheng RQ, Wang QH, Lu MD, et al. Liver fibrosis in chronic viral hepatitis: an ultrasonographic study. World J Gastroenterol 2003; 9: 2484-2489.
17. Gaiani S, Gramantieri L, Venturoli N, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997; 27: 979-985.
18. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-408.
19. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2007; 5: 1214-1220.
20. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
21. Colletta C, Smirne C, Fabris C, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-845.
22. Berends MA, Snoek J, de Jong EM, et al. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: FibroTest predicts presence and FibroScan predicts the absence of significant liver fibrosis. Liver Int 2007; 27: 639-645.